[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker. - Vu KV; Otis HG; Brandmaier A; Osborne JR; Stieg PE; Ramakrishna RR; Haghdel A; Kim SH; Liechty B; Rosen K; Beal K; Pannullo SC; et al. (AJNR. American journal of neuroradiology, 2026)